Advertisement

Topics

Biopharm group continues efforts in fight against antibiotic resistance through investment

07:48 EST 15 Feb 2018 | EPM Magazine

Debiopharm Group, international biopharmaceutical group, has continued its efforts in the fight against antibiotic resistance by investing in antibiotic development through acquiring a minority stake in ABAC Therapeutics.

Original Article: Biopharm group continues efforts in fight against antibiotic resistance through investment

NEXT ARTICLE

More From BioPortfolio on "Biopharm group continues efforts in fight against antibiotic resistance through investment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...